Showing results (2191-2200 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|September 20, 2001
A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chestC M George, D J Haraf, A M Mauer, et al.
Investigational New Drugs|July 9, 2002
New trial designs to assess antitumor and antiproliferative agents in prostate cancerWalter Stadler
Investigational New Drugs|May 15, 2002
Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignanciesSuzanne Jones, John Hainsworth, Howard A Burris, et al.
Investigational New Drugs|January 1, 1995
Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere)D J Dykes, M C Bissery, S D Harrison, et al.
Investigational New Drugs|January 1, 1995
Hepsulfam distribution in blood, plasma and cerebrospinal fluid of baboonsM V Marshall, K D Carey, D D Von Hoff, et al.
Investigational New Drugs|January 1, 1995
A phase II trial of piroxantrone in disseminated malignant melanoma. A Southwest Oncology Group studyJ A Sosman, L E Flaherty, P Y Liu, et al.
Investigational New Drugs|November 1, 1993
A phase I trial of fazarabine in refractory pediatric solid tumors. A Pediatric Oncology Group studyM L Bernstein, V M Whitehead, H Grier, et al.
Investigational New Drugs|February 1, 1993
Chloroquinoxaline sulfonamide: a sulfanilamide antitumor agent entering clinical trialsJ S Fisherman, B L Osborn, H G Chun, et al.
Investigational New Drugs|February 1, 1993
Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanomaK Dhingra, N Papadopoulos, S Lippman, et al.
Investigational New Drugs|February 1, 1993
Amonafide treatment of refractory esophageal cancer. A Southwest Oncology Group studyE Poplin, T Fleming, J S MacDonald, et al.
Pageof 372